CERo Therapeutics Holdings Inc.

NASDAQ: CERO
Share price (12/20/24): $0.06
Market cap (12/20/24): $8.433 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3 2024 – amended

ended 09/30/24 Q3

Late quarterly filing notification for Q3 2024

ended 06/30/24 Q2

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Initial registration of new securities

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Initial registration of new securities

Ownership Filter

YK Bioventures Opportunities GP I, LLC

YK Bioventures Opportunities GP I, LLC, YK Bioventures Opportunities Fund I, L.P., Kossar Mitchell William, Yeung Gary Kahing

YK Bioventures Opportunities GP I, LLC, YK Bioventures Opportunities Fund I, L.P., Kossar Mitchell William, Yeung Gary Kahing

Ehrlich Christopher B

News Filter

Inc. Appoints Chris Ehrlich CEO

Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

Material Definitive Agreement, Shareholder Vote Results, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC